OTC Antihistamine Tablets Recalled for Failed Quality Specifications
L. Perrigo Company is recalling 1,920 cartons of Exchange Select Aller Ease (Fexofenadine Hydrochloride) 180 mg tablets nationwide due to failed impurity and degradation specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The issue is failed impurities and degradation specifications, indicating a manufacturing quality control failure rather than an acute safety hazard. This is a precautionary recall.
Plain-English summary
L. Perrigo Company is recalling 1,920 cartons of Exchange Select Aller Ease (Fexofenadine Hydrochloride) 180 mg tablets due to failed impurities and degradation specifications. The affected lot is 2ER0285 with an expiration date of January 2024, and the product was distributed nationwide through military exchanges.
The product failed to meet regulatory specifications for impurities and degradation during quality testing. No illnesses or injuries have been reported in connection with this product.
Consumers who have purchased this product should stop using it and contact their healthcare provider or pharmacist with any questions. Customers may return the product to the point of sale for a refund or replacement.
The recalled product
- Product
- EXCHANGE SELECT ALLER EASE (FEXOFENADINE HYDROCHLORIDE)
- Brand
- EXCHANGE SELECT ALLER EASE
- Manufacturer
- L. Perrigo Company
- Category
- Drug — OTC Antihistamine
- Hazard
- Affected units
- 1,920
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2ER0285
- Exp. date 01/24
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by L. Perrigo Company under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · L. Perrigo Company
See all →- HighFexofenadine Tablets Recalled for Failed Impurity and Degradation Specifications
FDA (Drugs) · 2023-07-19
- HighBASIC CARE Allergy Tablets Recalled Due to Failed Quality Specifications
FDA (Drugs) · 2023-07-19
- HighFexofenadine Hydrochloride Tablets Recalled for Failed Purity Specifications
FDA (Drugs) · 2023-07-19
- HighAllergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Allergy Relief Tablets Recalled for Failed Manufacturing Specifications
FDA (Drugs) · 2023-07-19
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17